1. Home
  2. HOFT vs IPHA Comparison

HOFT vs IPHA Comparison

Compare HOFT & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$13.12

Market Cap

160.4M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$2.08

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
IPHA
Founded
1924
1999
Country
United States
France
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.4M
165.3M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
HOFT
IPHA
Price
$13.12
$2.08
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
29.9K
175.2K
Earning Date
04-16-2026
03-26-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$278,139,000.00
N/A
Revenue This Year
$17.37
$180.36
Revenue Next Year
$9.00
N/A
P/E Ratio
$128.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.62
$1.18
52 Week High
$18.09
$2.71

Technical Indicators

Market Signals
Indicator
HOFT
IPHA
Relative Strength Index (RSI) 32.99 52.90
Support Level $11.99 $1.67
Resistance Level $13.63 $2.66
Average True Range (ATR) 0.53 0.09
MACD -0.16 -0.02
Stochastic Oscillator 14.95 41.73

Price Performance

Historical Comparison
HOFT
IPHA

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: